Retinal Diseases and Treatments
Retinal Diseases and Treatments is a research topic within Ophthalmology. Science Explorer counts 56k research works in it since 1950. 21.3% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on research related to age-related macular degeneration (AMD) and diabetic retinopathy. It covers topics such as the role of oxidative stress, vascular endothelial growth factor, complement factor H polymorphism, and choroidal thickness in the pathogenesis and treatment of these diseases. Additionally, it explores the use of intravitreal injections and optical coherence tomography angiography in understanding and managing AMD and diabetic retinopathy.
- Macular Degeneration
- Retinal Pigment Epithelium
- Diabetic Retinopathy
- Oxidative Stress
- Vascular Endothelial Growth Factor
- Choroidal Thickness
- Intravitreal Injection
- Complement Factor H Polymorphism
- Optical Coherence Tomography Angiography
- Inflammation
- Research works
- 56k fractional, since 1950
- In the world top 10%
- 12k per year above
- Top-10% rate
- 21.3% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +27% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Retinal Diseases and Treatments research?
By volume, China and the United States publish the most (2.1k and 2.1k works in 2022–2025).
By volume, 2022–2025
- 1 China 2.1k works
- 2 United States 2.1k works
- 3 India 983 works
- 4 United Kingdom 509 works
- 5 Japan 454 works
- 6 South Korea 374 works
- 7 Türkiye 344 works
- 8 Germany 342 works
- 9 Italy 341 works
- 10 Spain 314 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Retinal Diseases and Treatments research?
By volume in 2022–2025, Sun Yat-sen University publishes the most Retinal Diseases and Treatments research, followed by University College London and Harvard University.
By volume, 2022–2025
- 1 Sun Yat-sen UniversityChina 87 works
- 2 University College LondonUnited Kingdom 58 works
- 3 Harvard UniversityUnited States 46 works
- 4 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 44 works
- 5 L V Prasad Eye InstituteIndia 42 works
- 6 Capital Medical UniversityChina 39 works
- 7 Aravind Eye HospitalIndia 38 works
- 8 Massachusetts Eye and Ear InfirmaryUnited States 38 works
- 9 Wenzhou Medical UniversityChina 37 works
- 10 Beijing Tongren HospitalChina 37 works
Who are the leading researchers in Retinal Diseases and Treatments?
The most-cited researchers publishing on Retinal Diseases and Treatments include Jeremy Grimshaw, Tianjing Li and Jost B. Jonas.
- 1 Jeremy Grimshaw Canada 14k citations
- 2 Tianjing Li United States 13k citations
- 3 Jost B. Jonas Germany 7.7k citations
- 4 Serge Resnikoff Australia 4.5k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Retinal Diseases and Treatments research done?
The largest centres of Retinal Diseases and Treatments research in 2022–2025 are Beijing (China), Shanghai (China), London (United Kingdom) and Seoul (South Korea). Among places with at least 20 works in it, it is an unusually large share of all research in Brecksville, East Melbourne and Madurai.
Largest cities, 2022–2025
Where it is the local speciality
- BrecksvilleUS · 20.6 works168×
- East MelbourneAU · 25.7 works84×
- MaduraiIN · 39.2 works14×
Location quotient: how much more of its research is in Retinal Diseases and Treatments than the world average.
Where is the best place to study Retinal Diseases and Treatments?
Among universities, judged by research, Duke-NUS Medical School, Medical University of Vienna and Queen's University Belfast score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Duke-NUS Medical SchoolSingapore | 70.6 | 35.5% | 19.0× | 15 | +367.0% |
| 2 | Medical University of ViennaAustria | 69.0 | 44.8% | 9.7× | 32 | +9.1% |
| 3 | Queen's University BelfastUnited Kingdom | 60.0 | 39.0% | 6.8× | 23 | +77.8% |
| 4 | Vita-Salute San Raffaele UniversityItaly | 59.6 | 23.3% | 16.9× | 24 | +93.1% |
| 5 | Wenzhou Medical UniversityChina | 58.9 | 26.1% | 10.1× | 37 | +38.2% |
| 6 | Gunma UniversityJapan | 54.9 | 52.6% | 8.1× | 8 | +9.1% |
| 7 | Tianjin Medical UniversityChina | 54.7 | 24.9% | 13.6× | 29 | +12.3% |
| 8 | Sun Yat-sen UniversityChina | 54.1 | 28.5% | 5.0× | 87 | +21.4% |
| 9 | University of Eastern FinlandFinland | 52.4 | 37.0% | 6.0× | 13 | +108.2% |
| 10 | University of California, Los AngelesUnited States | 51.4 | 34.5% | 2.7× | 27 | +172.5% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Retinal Diseases and Treatments research growing?
Output in 2018–2022 was 27% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Retinal Diseases and Treatments.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.